Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.

Survivin is known as an inhibitor of apoptosis and a positive regulator of cell division. We have recently identified survivin as a predictor of joint destruction in patients with rheumatoid arthritis (RA). Flt3 ligand (Flt3L) is expressed in the inflamed joints and has adjuvant properties in arthri...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sofia E M Andersson, Mattias N D Svensson, Malin C Erlandsson, Mats Dehlin, Karin M E Andersson, Maria I Bokarewa
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/297dd88839fc489fa551ac8d2df3b959
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:297dd88839fc489fa551ac8d2df3b959
record_format dspace
spelling oai:doaj.org-article:297dd88839fc489fa551ac8d2df3b9592021-11-18T08:11:39ZActivation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.1932-620310.1371/journal.pone.0047668https://doaj.org/article/297dd88839fc489fa551ac8d2df3b9592012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23082191/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Survivin is known as an inhibitor of apoptosis and a positive regulator of cell division. We have recently identified survivin as a predictor of joint destruction in patients with rheumatoid arthritis (RA). Flt3 ligand (Flt3L) is expressed in the inflamed joints and has adjuvant properties in arthritis. Studies on 90 RA patients (median age 60.5 years [range, 24-87], disease duration 10.5 years [range, 0-35]) show a strong positive association between the levels of survivin and Flt3L in blood. Here, we present experimental evidence connecting survivin and Flt3L signaling. Treatment of BALB/c mice with Flt3L led to an increase of survivin in the bone marrow and in splenic dendritic cells. Flt3L changed the profile of survivin splice variants, increasing transcription of the short survivin40 in the bone marrow. Treatment with an Flt3 inhibitor reduced total survivin expression in bone marrow and in the dendritic cell population in spleen. Inhibition of survivin transcription in mice, by shRNA lentiviral constructs, reduced the gene expression of Flt3L. We conclude that expression of survivin is a downstream event of Flt3 signaling, which serves as an essential mechanism supporting survival of leukocytes during their differentiation, and maturation of dendritic cells, in RA.Sofia E M AnderssonMattias N D SvenssonMalin C ErlandssonMats DehlinKarin M E AnderssonMaria I BokarewaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 10, p e47668 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sofia E M Andersson
Mattias N D Svensson
Malin C Erlandsson
Mats Dehlin
Karin M E Andersson
Maria I Bokarewa
Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.
description Survivin is known as an inhibitor of apoptosis and a positive regulator of cell division. We have recently identified survivin as a predictor of joint destruction in patients with rheumatoid arthritis (RA). Flt3 ligand (Flt3L) is expressed in the inflamed joints and has adjuvant properties in arthritis. Studies on 90 RA patients (median age 60.5 years [range, 24-87], disease duration 10.5 years [range, 0-35]) show a strong positive association between the levels of survivin and Flt3L in blood. Here, we present experimental evidence connecting survivin and Flt3L signaling. Treatment of BALB/c mice with Flt3L led to an increase of survivin in the bone marrow and in splenic dendritic cells. Flt3L changed the profile of survivin splice variants, increasing transcription of the short survivin40 in the bone marrow. Treatment with an Flt3 inhibitor reduced total survivin expression in bone marrow and in the dendritic cell population in spleen. Inhibition of survivin transcription in mice, by shRNA lentiviral constructs, reduced the gene expression of Flt3L. We conclude that expression of survivin is a downstream event of Flt3 signaling, which serves as an essential mechanism supporting survival of leukocytes during their differentiation, and maturation of dendritic cells, in RA.
format article
author Sofia E M Andersson
Mattias N D Svensson
Malin C Erlandsson
Mats Dehlin
Karin M E Andersson
Maria I Bokarewa
author_facet Sofia E M Andersson
Mattias N D Svensson
Malin C Erlandsson
Mats Dehlin
Karin M E Andersson
Maria I Bokarewa
author_sort Sofia E M Andersson
title Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.
title_short Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.
title_full Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.
title_fullStr Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.
title_full_unstemmed Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.
title_sort activation of fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/297dd88839fc489fa551ac8d2df3b959
work_keys_str_mv AT sofiaemandersson activationoffmsliketyrosinekinase3signalingenhancessurvivinexpressioninamousemodelofrheumatoidarthritis
AT mattiasndsvensson activationoffmsliketyrosinekinase3signalingenhancessurvivinexpressioninamousemodelofrheumatoidarthritis
AT malincerlandsson activationoffmsliketyrosinekinase3signalingenhancessurvivinexpressioninamousemodelofrheumatoidarthritis
AT matsdehlin activationoffmsliketyrosinekinase3signalingenhancessurvivinexpressioninamousemodelofrheumatoidarthritis
AT karinmeandersson activationoffmsliketyrosinekinase3signalingenhancessurvivinexpressioninamousemodelofrheumatoidarthritis
AT mariaibokarewa activationoffmsliketyrosinekinase3signalingenhancessurvivinexpressioninamousemodelofrheumatoidarthritis
_version_ 1718422095425175552